HOME >> MEDICINE >> NEWS
Positive Results Of Pivotal Phase III Trial With ENBREL In Patients With Early, Active Rheumatoid Arthritis

Immunex Plans To File With The FDA Seeking An Expanded Label For ENBREL To Slow Structural Joint Damage In Patients And to Improve The Signs And Symptoms Of Patients With Early, Active RA

SEATTLE - In patients with early, active rheumatoid arthritis (RA), the primary endpoints from a Phase III study showed that ENBREL® (etanercept) slowed the progression of the disease and reduced the signs and symptoms. ENBREL was found to be generally well tolerated in this clinical trial. This announcement was made today by Immunex Corporation (NASDAQ: IMNX) and Wyeth Ayerst, a division of American Home Products Corporation (NYSE: AHP), the two companies that are co-marketing ENBREL in North America.

Detailed data regarding this clinical trial with a more complete analysis will be presented at a medical meeting in the future. The results described herein are based on investigational data analyzed by Immunex. These data have not been reviewed by the U.S. Food and Drug Administration (FDA) as part of an application for regulatory approval.

"The completion of this major study represents another significant milestone in the development of ENBREL," said Peggy V. Phillips, senior vice president, pharmaceutical development, Immunex. "Based on the positive results of this study, Immunex intends to file a new supplemental biologics license application with the FDA seeking an expanded label for ENBREL to slow structural joint damage in patients with active RA and to improve the signs and symptoms of patients with early, active RA."

The Phase III pivotal study evaluated 633 RA patients with early, active disease who received ENBREL or methotrexate, using two primary endpoints:

  1. To study the ability of ENBREL to slow the progression of RA, the study utilized digitized x-ray data evaluation to monitor changes in joints. Structural damage to joints was measured over a one-year period using the Modified Sharp Sco
    '"/>


Contact: Tim Warner
warnert@immunex.com
206-470-4193
Immunex Corporation
10-May-1999


Page: 1 2 3 4

Related medicine news :

1. Positive mental attitude does not affect cancer survival
2. Positive outlook, sense of self-control can predict new coronary events, says Carnegie Mellon study
3. Anal Cancer Screening For HIV-Positive Gay And Bisexual Men Would Save Lives And Be Cost Effective, New Study Shows
4. Abgenix Reports Positive Survival Data From A Phase II Trial Of ABX-CBL In Graft Versus Host Disease
5. Signal Pharmaceuticals Announces Positive Results In Preclinical Study Of Novel Drug Leads For Treatment Of Osteoporosis
6. UCSF Study Finds Drug Treatment Can Be Cost Effective In Tanzania And Thailand For HIV-Positive Pregnant Women
7. Only Eight Percent Of San Francisco HIV-Positive Urban Poor Receive Protease Inhibitors
8. Cost-Effective Treatment Possible In Africa For HIV-Positive Pregnant Women If Drug Prices Lowered
9. Program Provides Treatment For Prison-Released HIV-Positive Women
10. Heart transplant survival: Results may be key to rejection prevention, detection, treatment
11. Docetaxel versus paclitaxel in breast cancer Results of worlds first head to head trial

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/3/2020)... ... September 03, 2020 , ... ... will be held Wednesday, April 7, to Saturday, April 10, 2021, at Wynn ... Spa Show is a national trade show for non-invasive medical aesthetic practices that ...
(Date:9/2/2020)... ... September 02, 2020 , ... ... for healthcare payers administering Medicare Advantage and Special Needs plans, is proud to ... America’s Health Insurance Plans (AHIP). RAM is supporting the event as a sponsor ...
(Date:9/1/2020)... ... 01, 2020 , ... Feeding Matters , the first organization in the ... (PFD), is pleased to announce that the U.S. Centers for Disease Control and Prevention ... the next edition of the U.S. International Classification of Diseases (ICD ) on ...
(Date:8/31/2020)... ... , ... Cardiothoracic surgeons at Allegheny General Hospital (AGH), part ... (CMU) to develop a new heart monitoring device designed to serve as an ... AGH/CMU team was recently awarded a “Trailblazer” grant from the National Institutes of ...
(Date:8/31/2020)... ... August 31, 2020 , ... ... 1,400 N95 face masks to medical first responders across the United States. Since ... donations of personal protective equipment (PPE) medical centers , hospitals , ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... ... ... flu season is right round the corner and the risk of getting caught by influenza ... it begins to harbor its effects on us. Already with the sudden outbreak of COVID ... our lives. Hence it has become even more relevant to keep oneself immune from any ...
(Date:8/26/2020)... ... August 26, 2020 , ... ... Care Helps Sports Injuries. The infographic breaks down ways that chiropractors can help ... recovery. , According to ScripHessco “Athletes have an unusual amount of pressure and ...
(Date:8/26/2020)... , ... August 26, 2020 , ... As the U.S. ... the daily routine for preventing the Coronavirus. Wear a mask, keep your distance, wash ... advocate Dr. Denis Burkitt said it best in 1977, “How much better it is ...
Breaking Medicine Technology:
Cached News: